Viewing Study NCT03706950


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-01 @ 1:43 AM
Study NCT ID: NCT03706950
Status: UNKNOWN
Last Update Posted: 2018-10-18
First Post: 2018-10-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-approval Observational Study of Elpida® in the First Line Therapy for HIV-1 Infected Patients With Background Standard ART
Sponsor: Viriom
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module